中国产 AFP 胃癌的特征分析。
Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.
机构信息
Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, Jiangsu Province, People's Republic of China.
出版信息
World J Surg Oncol. 2013 Oct 1;11:246. doi: 10.1186/1477-7819-11-246.
Abstract
α-Fetoprotein-producing gastric cancer (AFPGC) is a rare type of gastric cancer. The largest population of patients with AFPGC is found in China. In the present study, a total of 4,779 GC patients, including 317 AFPGC patients, from 11 clinical studies in China with a general AFPGC/GC ratio of 6.63% were summarized and analyzed. On the basis of analysis of the clinical data, the patients with AFPGC had larger tumor size, weaker cell differentiation, worse histopathological types, deeper serosal infiltration, more lymph node and liver metastases, poorer stages, shorter survival time and more positive expression of vascular endothelial growth factors than the patients without AFPGC. Our observation is consistent with previous results reported in studies of AFPGC. Overall, AFPGC is a subtype of GC with a poor prognosis.
摘要
甲胎蛋白阳性胃癌（AFPGC）是一种罕见的胃癌类型。AFPGC 患者数量最多的是中国。本研究共总结分析了来自中国的 11 项临床研究的 4779 例 GC 患者，其中 317 例为 AFPGC 患者，AFPGC/GC 比例一般为 6.63%。基于临床数据分析，AFPGC 患者的肿瘤体积较大，细胞分化较弱，组织病理学类型较差，浆膜浸润较深，淋巴结和肝转移较多，分期较差，生存时间较短，血管内皮生长因子表达阳性率较高。我们的观察结果与之前报道的 AFPGC 研究结果一致。总体而言，AFPGC 是一种预后不良的 GC 亚型。
相似文献
1
Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China.中国产 AFP 胃癌的特征分析。
World J Surg Oncol. 2013 Oct 1;11:246. doi: 10.1186/1477-7819-11-246.
2
An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.血清甲胎蛋白阳性胃癌患者的临床特征及预后分析
Minerva Med. 2015 Aug;106(4):185-91.
3
Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.甲胎蛋白阳性胃癌的临床病理及分子特征：重点关注两大主要亚型。
APMIS. 2022 Mar;130(3):169-180. doi: 10.1111/apm.13196. Epub 2021 Dec 22.
4
Clinicopathologic and prognostic characteristics of alpha-fetoprotein-producing gastric cancer.产甲胎蛋白胃癌的临床病理及预后特征
Oncotarget. 2017 Apr 4;8(14):23817-23830. doi: 10.18632/oncotarget.15909.
5
Re-evaluation of the prognosis of alpha-fetoprotein-producing gastric cancer from a single center: a case series study.甲胎蛋白阳性胃癌预后的单中心再评估：病例系列研究。
Langenbecks Arch Surg. 2023 Jan 25;408(1):66. doi: 10.1007/s00423-023-02817-4.
6
Clinical characteristics and treatments of patients with alpha-fetoprotein producing gastric carcinoma.甲胎蛋白阳性胃癌患者的临床特征和治疗方法。
Neoplasma. 2018 Mar 14;65(3):326-330. doi: 10.4149/neo_2018_170207N84.
7
Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.血清甲胎蛋白水平的动态变化可预测甲胎蛋白产生型胃癌的治疗反应及预后。
Medicine (Baltimore). 2020 Nov 20;99(47):e23326. doi: 10.1097/MD.0000000000023326.
8
ANGPTL6-mediated angiogenesis promotes alpha fetoprotein-producing gastric cancer progression.ANGPTL6 介导的血管生成促进甲胎蛋白产生的胃癌进展。
Pathol Res Pract. 2019 Aug;215(8):152454. doi: 10.1016/j.prp.2019.152454. Epub 2019 May 23.
9
Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer.甲胎蛋白阳性胃癌的单细胞特征和恶性调控
Cancer Med. 2023 May;12(10):12018-12033. doi: 10.1002/cam4.5883. Epub 2023 Apr 5.
10
Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets.甲胎蛋白产生型胃癌的全外显子组测序揭示了基因组特征和治疗靶点。
Nat Commun. 2021 Jun 24;12(1):3946. doi: 10.1038/s41467-021-24170-0.
引用本文的文献
1
A Case of Curative Surgery after Effective Chemotherapy for Gastric Adenocarcinoma with Enteroblastic Differentiation Accompanied by Synchronous Multiple Liver Metastases.1例伴有同步多发肝转移的具有成肠细胞分化的胃腺癌经有效化疗后行根治性手术的病例。
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0205. Epub 2025 Jul 9.
2
Alpha fetoprotein (AFP)-producing gastric cancer: clinicopathological features and treatment strategies.产生甲胎蛋白的胃癌：临床病理特征与治疗策略
Cell Biosci. 2025 Jun 10;15(1):82. doi: 10.1186/s13578-025-01424-8.
3
α‑Fetoprotein‑positive hepatoid adenocarcinoma of the stomach and a new classification: A case report.胃α-甲胎蛋白阳性肝样腺癌及新分类：病例报告
Oncol Lett. 2024 Oct 3;28(6):586. doi: 10.3892/ol.2024.14717. eCollection 2024 Dec.
4
Recent developments in immunotherapy for gastrointestinal tract cancers.胃肠道肿瘤的免疫治疗新进展。
J Hematol Oncol. 2024 Aug 9;17(1):65. doi: 10.1186/s13045-024-01578-x.
5
Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study.联合zimberelimab 加仑伐替尼和化疗治疗甲胎蛋白升高的晚期胃癌患者（AFPGC）：一项 1 期剂量递增研究。
Cancer Immunol Immunother. 2024 Jun 4;73(8):154. doi: 10.1007/s00262-024-03743-0.
6
Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature.甲胎蛋白产生型胃癌全胃切除术后使用纳武利尤单抗继以伊立替康治疗的长期生存：一例病例报告及文献复习
Surg Case Rep. 2023 May 8;9(1):71. doi: 10.1186/s40792-023-01653-4.
7
Case report: Significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer.病例报告：晚期甲胎蛋白阳性胃癌对PD-1抑制剂耐药后对PD-L1抑制剂有显著反应。
Front Oncol. 2022 Oct 27;12:962126. doi: 10.3389/fonc.2022.962126. eCollection 2022.
8
Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer.阿帕替尼治疗甲胎蛋白产生型胃癌的疗效与安全性。
Transl Oncol. 2021 Feb;14(2):101004. doi: 10.1016/j.tranon.2020.101004. Epub 2020 Dec 28.
9
The clinicopathological features and prognosis of serum AFP positive gastric cancer: a report of 16 cases.血清甲胎蛋白阳性胃癌的临床病理特征及预后：附16例报告
Int J Clin Exp Pathol. 2020 Sep 1;13(9):2439-2446. eCollection 2020.
10
Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis.胃癌肝转移的手术切除治疗效果：一项回顾性分析。
World J Surg Oncol. 2020 Feb 24;18(1):41. doi: 10.1186/s12957-020-01816-9.
本文引用的文献
1
Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.甲胎蛋白阳性胃癌的临床病理特征及预后因素分析：104 例病例分析。
J Surg Oncol. 2010 Sep 1;102(3):249-55. doi: 10.1002/jso.21624.
2
Alpha-fetoprotein-producing early gastric cancer of the remnant stomach: report of a case.残胃产甲胎蛋白的早期胃癌：病例报告
Surg Today. 2007;37(11):995-9. doi: 10.1007/s00595-007-3501-0. Epub 2007 Oct 25.
3
Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype.胃肝样腺癌：与肠型表型相关的组织发生及进展
Hum Pathol. 2007 Jun;38(6):857-63. doi: 10.1016/j.humpath.2006.10.020. Epub 2007 Feb 22.
4
5
Demonstration of a new protein fraction in serum from the human fetus.人胎儿血清中一种新蛋白质组分的证实。
Scand J Clin Lab Invest. 1956;8(2):174. doi: 10.3109/00365515609049266.
6
AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.产甲胎蛋白胃癌：270例患者预后因素的多变量分析
Oncology. 2003;65(2):95-101. doi: 10.1159/000072332.
7
Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein.产生甲胎蛋白的胃癌细胞中血管内皮生长因子（VEGF）和血管内皮生长因子C（VEGF-C）表达的评估
J Gastroenterol. 2003;38(6):540-7. doi: 10.1007/s00535-002-1099-y.
8
Clinicopathologic features of gastric cancers producing alpha-fetoprotein.产生甲胎蛋白的胃癌的临床病理特征
Dig Surg. 2002;19(5):359-65; discussion 365. doi: 10.1159/000065838.
9
Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis.产甲胎蛋白胃癌：细胞增殖、凋亡及血管生成的组织化学分析
Am J Gastroenterol. 1999 Jun;94(6):1658-63. doi: 10.1111/j.1572-0241.1999.01158.x.
10
nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
Oncology. 1999;56(2):122-8. doi: 10.1159/000011952.
Zotero 插件